Patents Assigned to Sanabio, LLC
  • Polynucleotides heterodimers of soluble interferon receptors and uses thereof
    Patent number: 12129288
    Abstract: The present disclosure provides soluble interferon receptors. The methods of the disclosure can be used to treat or prevent a condition associated with an abnormal immune response.
    Type: Grant
    Filed: February 4, 2021
    Date of Patent: October 29, 2024
    Assignee: Sanabio, LLC
    Inventors: James Arthur Posada, Pamela Smolak
  • Heterodimers of soluble interferon receptors and uses thereof
    Patent number: 10947295
    Abstract: The present disclosure provides soluble interferon receptors. The methods of the disclosure can be used to treat or prevent a condition associated with an abnormal immune response.
    Type: Grant
    Filed: August 22, 2018
    Date of Patent: March 16, 2021
    Assignee: Sanabio, LLC
    Inventors: James Arthur Posada, Pamela Smolak